Consolidated Balance Sheets (Parenthetical) - $ / shares |
Jul. 02, 2025 |
Jun. 30, 2025 |
Sep. 30, 2024 |
Sep. 30, 2023 |
|---|---|---|---|---|
| Common stock, par value | $ 0.01 | |||
| Common stock, shares authorized | 1,000 | |||
| Common stock, shares issued | 0 | |||
| Common stock, shares outstanding | 0 | |||
| Sonnet BioTherapeutics Holdings, Inc. [Member] | ||||
| Preferred stock, par value | $ 0.0001 | $ 0.0001 | $ 0.0001 | |
| Preferred stock, shares authorized | 5,000,000 | 5,000,000 | 5,000,000 | |
| Preferred stock, shares issued | 0 | 0 | 0 | |
| Preferred stock, shares outstanding | 0 | 0 | 0 | |
| Common stock, par value | $ 0.0001 | $ 0.0001 | $ 0.0001 | |
| Common stock, shares authorized | 125,000,000 | 125,000,000 | 125,000,000 | |
| Common stock, shares issued | 3,332,728 | 650,284 | 218,786 | |
| Common stock, shares outstanding | 3,332,728 | 650,284 | 218,786 |
| X | ||||||||||
- Definition Face amount or stated value per share of common stock. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The maximum number of common shares permitted to be issued by an entity's charter and bylaws. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|